Clinical and Behavioral Outcomes During 4 Weeks of Home-Based Self-Administered Transcranial Direct Current Stimulation in Perinatal Women With Depressive Symptoms: Open-Label Exploratory Pilot Study
Park et al., 2026. JMIR Formative Research
This pilot study tested home-based, self-administered tDCS in pregnant and postpartum women with depressive symptoms. Participants also wore an activity tracker throughout.
- Design: An open-label study with 38 perinatal women and no control group.
- Treatment: Daily 30-minute sessions for 4 weeks at 1.5–2 mA, with the anode over the left dorsolateral prefrontal cortex and the cathode over the right.
- Main result: Depression scores fell significantly over 4 weeks (MADRS from 21.3 to 12.3, BDI from 24.8 to 16.1). Average daily steps rose from about 2,400 to 6,300.
- Safety: 26% of participants reported side effects, mostly mild skin irritation or headache. No one stopped treatment because of them.
CONCLUSION: Home-based tDCS appears feasible and well tolerated for perinatal depression. Randomized sham-controlled trials are needed to confirm its effects.